SMTL ID : 8v1o.4 (3 other biounits)

Crystal structure of IRAK4 kinase domain with compound 4

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.92 Å

Oligo State

monomer

Ligands

1 x Y9T: N-[2-(3-hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide(Non-covalent)

Y9T.1: 13 residues within 4Å: Chain A: M.59, V.67, A.78, K.80, V.113, Y.129, V.130, Y.131, M.132, P.133, G.135, T.147, L.185 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.67, A:A.78, A:V.113, A:Y.129, A:Y.129, A:Y.131, A:T.147, A:L.185, A:L.185 Hydrogen bonds: A:M.132, A:R.140, A:D.145 Water bridges: A:D.145

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 5 residues within 4Å: Chain A: L.150, S.151, K.284, M.285, N.286 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Weiss, M.M. et al., Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma. J.Med.Chem. (2024)

Release Date

2024-07-03

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence